Physician profile
Ajay Singh
NPI 1184807786
$65,910.54
in general payments reported to CMS, 2019-2025
20 companies · $8,036 in 2025
The $8,036 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,692 · 2020: $11K · 2021: $770 · 2022: $13K · 2023: $14K · 2024: $15K · 2025: $8,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $6,613 · Food and Beverage: $2,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,050.00 |
| Travel and Lodging | $6,612.79 |
| Food and Beverage | $2,562.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $45,429.64 | 2022-2025 | Ozurdex |
| Allergan, INC. | $14,438.88 | 2019-2022 | |
| Alimera Sciences, INC. | $3,586.32 | 2019-2024 | Iluvien, Yutiq |
| Genentech USA, INC. | $748.68 | 2019-2025 | Vabysmo, Susvimo |
| Regeneron Healthcare Solutions, INC. | $363.75 | 2019-2024 | Eylea Hd |
| Apellis Pharmaceuticals, INC. | $231.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $198.48 | 2019 | |
| Astellas Pharma US INC | $176.59 | 2023-2025 | Izervay |
| Mallinckrodt Hospital Products INC. | $121.90 | 2025 | Acthar |
| Regeneron Pharmaceuticals, INC. | $118.18 | 2023 | Eylea |
| Cardinal Health 200 LLC | $112.72 | 2019 | |
| Ani Pharmaceuticals, INC. | $112.50 | 2025 | Purified Cortrophin Gel |
| The Cameron-Ehlen Group, INC. | $109.20 | 2023 | Tecnis Iol, Tecnis Simplicity, Healon Pro |
| Alcon Vision LLC | $41.34 | 2021-2024 | Constellation |
| Coherus Oncology, INC. | $27.36 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $27.25 | 2019-2020 | |
| Biogen, INC. | $22.18 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.45 | 2019 | |
| Baxter Healthcare | $14.59 | 2022 | |
| Iridex Corporation | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.